Merck Writes a $9.2 Billion Check for a Flu Drug That Could Change Everything

Verdict

Headline takes no side. We score CDTX +1.00 — strongly bullish.

Headline says

No call

No rating or direction in the headline

Expected · CDTX

+1.00strongly bullish

−1 bearish0bullish +1

More positive than 98% of ticker scores this week

Actual